DEC 04, 2017 3:16 PM PST

Kill Cancer Gently, Kill Cancer More Completely

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

It’s tragically ironic that in cancer medicine, sometimes the process of killing off cancer cells can spur new tumors to form. The phenomenon is known as the “tumor growth paradox” and it illustrates the complexities behind tumor biology and highlights the need for more refined interventions when dealing with cancer.

To avoid inadvertently giving cancer the edge during treatment, researchers from the Institute of Systems Biology in Seattle, WA, say a more “gentle” approach may be key.

"Our studies, along with others, show that traditional cancer therapy may be a 'double-edged sword,' wherein the very treatment used to cure cancer is also helping it survive and grow,” explained the authors of the new study.

Chemotherapies and other treatments that hope to obliterate cancer cells can leave behind a collection of dead or dying cells. This mass of “tumor cell debris” is capable of triggering a malicious chain of events, including the promotion of new cancer cells.

As it turns out, the surface of these cells have a lipid called phosphatidylserine, which “generates a 'cytokine storm' of pro-inflammatory pro-tumorigenic cytokines." This inflammatory process can act like a breeze that reignites the few smoldering cancer cells that survived the initial treatment. And with time, another cancer wildfire begins anew.

The authors describe this as “the 'perfect storm' for cancer progression.” They also conclude this is how conventional chemotherapy “may contribute to tumor relapse.”

Instead of focusing on harsher and more poisonous cancer drugs, the research team approached the problem from a different angle: they wanted to reduce the wind that could reignite cancer’s progression.

To do so, the team used resolvins, “a natural product of tissue that serves as a stop signal to end the inflammatory process.” In essence, this compound acts like water to stop the smoldering process in cancer cells.

Indeed, treatment with resolvins quelled the inflammatory process and stopped cancer cells from progressing. Resolvins also improved the efficacy of other anticancer drugs when treated in combination.

“In brief, we learn that when it comes to cancer therapy: 'Thou shall not kill — or kill gently and remove dead bodies immediately,'" said Sui Huang, the study’s senior author, from the Institute of Systems Biology in Seattle, WA.

"The findings underscore the old idea that killing cancer cells with more and more effective drugs may backfire," added Huang. "The tumor tissue is a reactive system that turns cell-killing therapy into double-edge[d] swords: the more you kill the more you may stimulate the surviving tumor cells.”

“Overcoming the dilemma of debris-induced tumor progression is paramount if we are to prevent tumor recurrence of treatment-resistant tumors — the major reason for [the] failure of cancer therapy,” the authors said.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAR 15, 2021
Cell & Molecular Biology
Newly-ID'ed Organelle May Play a Role in Cancer Metastasis
MAR 15, 2021
Newly-ID'ed Organelle May Play a Role in Cancer Metastasis
Cells are packed full of organelles and molecules like proteins floating in a liquid known as cytoplasm. In recent years ...
MAR 23, 2021
Clinical & Molecular DX
AI Test Distinguishes Cancer Cells From Healthy Ones Based on Acidity Levels
MAR 23, 2021
AI Test Distinguishes Cancer Cells From Healthy Ones Based on Acidity Levels
Researchers have developed a new way of differentiating cancer cells from healthy ones—by how acidic they are. The ...
APR 03, 2021
Drug Discovery & Development
Why Are Some Cancer Therapeutics Ineffective?
APR 03, 2021
Why Are Some Cancer Therapeutics Ineffective?
Why don’t some cancer therapeutics not work in humans when they were successful in mice? The answer to this questi ...
MAY 02, 2021
Cancer
Evaluating early learning skills in child survivors of retinoblastoma
MAY 02, 2021
Evaluating early learning skills in child survivors of retinoblastoma
A report published recently in the Journal of Clinical Oncology highlights the need for early intervention resources for ...
MAY 19, 2021
Health & Medicine
Who Ages Better, Men or Women?
MAY 19, 2021
Who Ages Better, Men or Women?
The answer depends on what's considered more important – quantity or quality of years?  Previous studies ...
MAY 31, 2021
Immunology
Engineering Faster, More Agile T Cell Cancer Fighters
MAY 31, 2021
Engineering Faster, More Agile T Cell Cancer Fighters
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...
Loading Comments...